Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
SMAC 类似物 birinapant 在复发性铂耐药或难治性上皮性卵巢癌患者中的 2 期研究的药效学指标和临床结果
期刊:Cancer
影响因子:6.1
doi:10.1002/cncr.29783
Anne M Noonan #, Kristen P Bunch #, Jin-Qiu Chen, Michelle A Herrmann, Jung-Min Lee, Elise C Kohn, Ciara C O'Sullivan, Elizabeth Jordan, Nicole Houston, Naoko Takebe, Robert J Kinders, Liang Cao, Cody J Peer, W Douglas Figg, Christina M Annunziata